期刊文献+

重型再生障碍性贫血患者树突细胞亚群及其与淋巴细胞转录因子T-bet表达的相关性 被引量:3

Study on the dendritic cell subsets in peripheral blood and its relationship with the expressions of T- bet and GATA-3 in lymphocytes in severe aplastic anemia
原文传递
导出
摘要 目的探讨树突细胞(DC)亚群和淋巴细胞转录因子T-bet、GATA-3表达在获得性重型再生障碍性贫血(SAA)患者免疫失衡中的意义。方法采用流式细胞术检测29例SAA患者及16名健康人外周血DCl(HIA-DR^+Lin^-CD11c^+)、DC2(HLA-DR^+Lin^-CD123^+)数值及比例,半定量RT-PCR检测外周血T-bet mRNA和GATA-3 mRNA表达,ELISA法检测血浆IFNT、IL-4水平。结果SAA初治组、恢复组DC1占外周血单个核细胞比例分别为(0.44±0.24)%、(0.73±0.30)%,明显高于正常对照组[(0.29±0.10)%,P〈0.05]。三组DC2分别为(0.18±0.14)%、(0.28±0.20)%、(0.29±0.13)%,初治组低于对照组(P〈0.05)。SAA初治组、恢复组DC1/DC2比值分别为3.45±2.71、2.90±0.95,明显高于对照组(1.15±0.56),初治组与恢复组DC1/DC2比值差异无统计学意义(P〉0.05)。SAA初治组、恢复组及对照组T-bet的相对表达量分别为0.37±0.07、0.20±0.07、0.17±0.05,初治组明显高于恢复组和对照组(P〈0.05)。三组中GATA-3的相对表达量差异无统计学意义(P〉0.05)。初治组T-bet/GATA-3比值为0.72±0.13,明显高于恢复组(0.33±0.08)和对照组(0.35±0.11)。初治组血浆IFN7为(50.9±1.1)ng/L,明显高于恢复组[(49.7±0.9)ng/L]和正常对照组[(49.7±0.7)ng/L]。T-bet表达与DC1/DC2比值、IFNγ/水平呈显著正相关(r=0.445和r=0.402,P〈0.01)。结论DC1/DC2和T-bet/GATA-3比值失衡可作为判断SAA患者免疫状态的指标。T-bet的相对表达量与SAA患者的病情有关,病情好转后T-bet/GATA-3恢复平衡。SAA患者DC亚群恢复迟于血常规恢复,因此不可过早停用免疫抑制剂。 Objective To investigate the relationship between the dendritic cell (DC) subsets and transcriptive factors, T-bet, GATA-3, and immune imbalance in acquired severe aplastie anemia (SAA). Methods The DC1 ( HLA-DR ^+ Lin ^- CD11 e ^+ ) and DC2 ( HLA-DR ^+ Lin^ - CD123^ + ) in peripheral blood mononuelear ceils (PBMNC) were measured with flow cytometry ( FCM), the expressions of T-bet mRNA and GATA-3 mRNA in PBMNC with semiquantitative RT-PCR and the plasma level of IFNγ and IL-4 with ELISA in 29 SAA patients and 16 healthy controls. Results ①The percentages of DC1 in PBMNC were (0.44 ± 0.24)% and (0.73 ± 0.30)% in untreated and recovered SAA patients respectively, both were higher than that in controls (0.29 ± 0.10) % ( P 〈 0.05 ). The percentage of DC2 in the untreated cases was lower than that of recovered ones or controls [(0. 18 ±0. 14) % vs (0.28 ±0.20) % and (0.29 ± 0.13) %] (P 〈 0.05 ). DC1/DC2 ratios were 3.45 ± 2.71 and 2.90 ± 0.95 in untreated and recovered groups respectively, both were higher than that in controls (1.15 ± 0.56) (P 〈0.05 ). No statistic difference in DC1/DC2 ratio was found between untreated and recovered patients ( P 〈 0.05 ). ② The relative mRNA expression levels of trauscriptive factor T-bet were 0.37 ± 0.07, 0.20 ± 0.07 and 0.17 ± 0.05 in the above 3 groups, respectively, untreated group being higher than that of recovered group or healthy controls (P 〈 0.05). There was no statistic difference of GATA-3 expression among the 3 groups ( P 〉 0.05 ). T-bet/ GATA-3 ratio was 0.72 ± 0.13 in untreated group, being higher than that of recovered group (0.33 ± 0.08 ) or controls (0.35 ±0.11 ). ③ The plasma level of IFN3, in the untreated group was (50.9 ± 1.1 ) ng/L, which was higher than that of recovered group [ ( 49.7 ± 0.9 ) ng/L ] or controls [ ( 49.7 ± 0.7 ) ng/L].④There was significant positive correlations between T-bet and DC1/DC2 ratio ( r = 0. 445, P 〈 0.01 ) , as well as between T-bet and IFNγ ( r = 0. 402, P 〈 0.01 ). Conclusion Either DC1/DC2 or T-bet/GATA-3 ratio might become an index to estimate immune imbalance. High-expressed T-bet was related to the progress of SAA. In patients with SAA, DC1/DC2 ratio returns to normal range later than that of routine blood test does, indicating that immunosuppressive therapy should not be withdrawn too earlier.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第11期733-736,共4页 Chinese Journal of Hematology
基金 基金项目:国家自然科学基金(30470749、30670886)
关键词 贫血 再生障碍性 树突细胞 转录因子 T-BET 转录因子 GATA-3 Anemia, aplastic Dendritic cell Transcriptive factor, T-bet Transcriptive factor, GATA-3
  • 相关文献

参考文献3

二级参考文献13

  • 1Ruegg CL,Rajasekar S,Stein BS,et al.Degradation of CD4 following phorbol-induced internalization in human T lymphocytes.Evidence for distinct endocytic routing of CD4 and CD3.J Biol Chem,1992,267:18837-18843.
  • 2Rostaing L,Tkaczuk J,Durand M,et al.Kinetics of intracytoplasmic Thl and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells.Cytometry,1999,35:318-328.
  • 3Weiner HL.Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells.Immunol Rev,2001,182:207-214.
  • 4Anderton SM.Peptide-based immunotherapy of autoimmunity:a path of puzzles,paradoxes and possibilities.Immunology,2001,104:367-376.
  • 5Thomson CT,Kalergis AM,Sacchettini JC,et al.A structural difference limited to one residue of the antigenic peptide can profoundly altered biological outcome of the TCR peptide MHC class Ⅰ interaction.J Immunol,2001,166:3994-3997.
  • 6Cochran JR,Cameron TO,Stem LJ.The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class Ⅱ oligomers.Immunity,2000,12:241-250.
  • 7Dybedal I,Guan F,Borge OJ,et al.Transforming growth factor-beta 1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells.Blood,1997,90:3395-3403.
  • 8刘杰,田志刚,冯进波,魏海明.人肿瘤细胞中Th2类细胞因子的强势表达[J].中华肿瘤杂志,1998,20(2):105-107. 被引量:50
  • 9何广胜,邵宗鸿,张益枝,刘鸿,李克,宋鲁燕,郑以洲,陈桂彬,和虹,赵明峰,施均,张泓,储榆林,钱林生,杨天楹,杨崇礼.序贯强化免疫抑制并用造血生长因子治疗重型再生障碍性贫血[J].中华血液学杂志,2001,22(4):177-181. 被引量:41
  • 10熊维宁,徐永健,张珍祥,王孝养.核因子κB和蛋白激酶C对哮喘Th2类细胞因子表达的调控[J].中华结核和呼吸杂志,2001,24(6):355-359. 被引量:27

共引文献69

同被引文献27

  • 1涂梅峰,邵宗鸿,刘鸿,何广胜,施均,白洁,曹燕然,王化泉,邢莉民,崔振珠,孙娟,陈辉树,薛艳萍,杨崇礼.重型再生障碍性贫血患者外周血树突细胞亚群及共刺激分子表达的研究[J].中华血液学杂志,2006,27(9):611-615. 被引量:14
  • 2庞妍(综述),肖扬(审校).造血负性调控因子与再生障碍性贫血发病机制的研究进展[J].国际输血及血液学杂志,2007,30(1):55-57. 被引量:5
  • 3邵宗鸿,杨崇礼.再生障碍性贫血//张之南,沈悌.血液病诊断与疗效标准.3版.北京:科学技术出版社,2007:19.
  • 4Lehtonen A, Ahlfors H, Veckman V, et al. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol, 2007, 82:710-720.
  • 5Karni A, Abraham M, Monsonego A, et al. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J Immunol, 2006, 177:4196-4202.
  • 6Gu Y, Zhang J, Peng J, et al. Elevated expression of IL-12 and IL-23 in patients with aplastie anemia. Int J Lab Hematol, 2009, 31:207-214.
  • 7Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol, 2008 ; 15 (3) : 162 - 168.
  • 8Szabo S J, Kim ST, Costa GL, et al. A novel transcription factor, T- bet, directs Th1 lineage commitment. Cell, 2000; 100 ( 6 ) :655 - 669.
  • 9Lugo-Vilarino G, Maldonado-Lopez R, Possemato R, et al. T-bet is required for optimal production of IFN-γ and antigen- specific T cell activation by dendritic ceils. Proc Nail Acad Sci USA, 2003; 100 ( 13 ) :7749 - 7754.
  • 10Shin HI, Lee JB, Park SH, et al. T-bet expression is regulated by EGRl-mediated signaling in activated T cells. Clin Immunol, 2009;131(3) :385 -394.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部